Lucid Diagnostics (LUCD) Notes Payables (2023 - 2025)
Lucid Diagnostics (LUCD) has disclosed Notes Payables for 3 consecutive years, with $22.3 million as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Notes Payables rose 118.63% year-over-year to $22.3 million, compared with a TTM value of $22.3 million through Sep 2025, up 118.63%, and an annual FY2024 reading of $18.6 million, up 33.33% over the prior year.
- Notes Payables was $22.3 million for Q3 2025 at Lucid Diagnostics, down from $25.3 million in the prior quarter.
- Across five years, Notes Payables topped out at $32.8 million in Q1 2025 and bottomed at $10.2 million in Q3 2024.
- Average Notes Payables over 3 years is $16.9 million, with a median of $14.0 million recorded in 2023.
- The sharpest move saw Notes Payables dropped 29.61% in 2024, then surged 149.62% in 2025.
- Year by year, Notes Payables stood at $14.0 million in 2023, then soared by 33.33% to $18.6 million in 2024, then increased by 19.89% to $22.3 million in 2025.
- Business Quant data shows Notes Payables for LUCD at $22.3 million in Q3 2025, $25.3 million in Q2 2025, and $32.8 million in Q1 2025.